Topiramate: Difference between revisions
From SEHK Wiki
| Line 41: | Line 41: | ||
*Initially 0.5 -1 mg/kg at night for the first week, | *Initially 0.5 -1 mg/kg at night for the first week, | ||
*Increased thereafter by 0.5 – 1 mg/kg every 1 or 2 weeks, to an initial target dose of 100 mg (about 2 mg/kg) daily in 2 divided doses. | *Increased thereafter by 0.5 – 1 mg/kg every 1 or 2 weeks, to an initial target dose of 100 mg (about 2 mg/kg) daily in 2 divided doses. | ||
|- | |||
| | |||
| As adjunctive therapy, CHILD form 2 years of age: | |||
*1 – 3 mg/kg once daily (maximum 25 mg). This is given as a single dose at night for 1 week, then | |||
*Increased by 1 to 3 mg/kg every 1 or 2 weeks until the effective dose is reached. | |||
*About 5 to 9 mg/kg daily is usually required. | |||
|} | |} | ||
Revision as of 22:41, 5 October 2020
Introduction
Topiramate is a medication used to treat epilepsy and prevent migraines. For epilepsy this includes treatment for generalized or focal seizures. It is also used as adjunctive treatment for seizures associated with Lennox-Gastaut syndrome.
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Topiramate Tablet 25 mg | TOPI01 | P1S1S3 |
| Topiramate Tablet 50 mg | TOPI01 | P1S1S3 |
| Topiramate Tablet 100 mg | TOPI03 | P1S1S3 |
Mechanism of Action
Anticonvulsant medication. It inhibits the sodium channels, calcium channels, GABA-A receptors, and carbonic anhydrase isoenzymes, contributing to the antiseizure effects.
Dosage
| For both adjunctive and monotherapy of epilepsy | By mouth
ADULT:
|
|---|---|
For monotherapy, CHILD 6 – 17 years:
| |
As adjunctive therapy, CHILD form 2 years of age:
|
